Searchable abstracts of presentations at key conferences in endocrinology

ea0068oc3 | Abstracts | UKINETS2019

Incidence and prevalence of neuroendocrine neoplasms reported in England from 2015 to 2017

White Benjamin E , Bouvier Catherine , Genus Tracey , Rous Brian , Srirajaskanthan Rajaventhan , Chandrakumaran Kandiah , Ramage John K

Introduction: Previously published UK Cancer Registry data showed incidence of Neuroendocrine Neoplasms rising between 2001 and 2015. This was higher than had been thought (Genus et al.). We report more recent data with more accurate coding (ICD-O-3).Aim: To analyse National Cancer Registration and Analysis Service (NCRAS) data on Neuroendocrine Neoplasias (NENs) in England including years 2015–2017.Methods: Public He...

ea0080OC1 | Oral Communications | UKINETS2021

Incidence, prevalence of survival of neuroendocrine neoplasia in England 1995–2018

White Benjamin E , Chandrakumaran Kandiah , Wong Kwok , Rous Brian , Bouvier Catherine , Van Hemelrijck Mieke , Srirajaskanthan Rajaventhan , Ramage John K

Introduction: Incidence of neuroendocrine neoplasia (NEN) is rising worldwide. The National Cancer Registry and Analysis Service allows accurate study of NEN in England. Aim: Calculate incidence and prevalence of NEN in England from 1995-2018. Calculate site-specific survival with multivariate analysis. Method: A population-based retrospective cohort study was performed. Data requested from NCRAS were reviewed by a steering group r...

ea0080p3 | Abstracts | UKINETS2021

Sex differences and survival of neuroendocrine neoplasia in England 2012–2018

White Benjamin E , Chandrakumaran Kandiah , Wong Kwok , Rous Brian , van Hemelrijck Mieke , Srirajaskanthan Rajaventhan , Ramage John K

Introduction: Sex differences have been noted at different sites of Neuroendocrine Neoplasia in previous registry studies across different countries. Analysis of National Cancer Registry and Analysis Service (NCRAS) data can help to clarify the significance and importance of this factor in England. Aim: To examine neuroendocrine neoplasia incidence and survival by sex, site and stage. Method: A population-based, cohort study was pe...

ea0052oc3 | (1) | UKINETS2017

Incidence and prevalence of neuroendocrine tumours in England

Genus Tracey , Bouvier Catherine , Wong Kwok , Srirajaskanthan Rajaventhan , Rous Brian , Talbot Denis , Valle Juan , Khan Mohid , Pearce Neil , Elshafie Mona , Reed Nicholas , Luong Tu Vinh , Munir Alia , Ramage John

Introduction: Historically the incidence and prevalence of neuroendocrine tumours (NETs) has been difficult to establish due to issues with disease coding and data collection. Studies estimated the incidence of gastroenteropancreatic neuroendocrine tumours (GEP NETs) to be 1.3 per 100,000 per year (incidence hereafter given as cases per 100,000). However, the SEER USA data suggests a four-fold higher incidence, and prevalence of 35 per 100,000. This study aimed to identify the...

ea0052p12 | (1) | UKINETS2017

1-Year survival rates for neuroendocrine tumour patients in England

Genus Tracey , Bouvier Catherine , Wong Kwok , Srirajaskanthan Rajaventhan , Rous Brian , Talbot Denis , Valle Juan , Khan Mohid , Pearce Neil , Elshafie Mona , Reed Nicholas , Luong Tu Vinh , Munir Alia , Ramage John

Introduction: Accurate survival data for patients with neuroendocrine tumours (NETs) across the UK has been difficult to capture. Individual centres often report good survival rates, however, national data has not previously been available.Materials and methods: NET patient survival was calculated for England using the Public Health England (PHE) National Cancer Registration and Analysis Service (NCRAS) dataset which captures tumour stage using TNM stagi...

ea0052p13 | (1) | UKINETS2017

Metachronous primary cancers in neuroendocrine tumour patients

Genus Tracey , Bouvier Catherine , Wong Kwok , Srirajaskanthan Rajaventhan , Rous Brian , Talbot Denis , Valle Juan , Khan Mohid , Pearce Neil , Elshafie Mona , Reed Nicholas , Luong Tu Vinh , Munir Alia , Ramage John

Introduction: Historically there has been an association with neuroendocrine tumours (NETs) and other cancers. However, this has not previously been well characterised. We aimed to determine the incidence of second malignancies in patients with NETs and investigate any association of the anatomical site of NETs with other malignancies.Materials and methods: 12,844 patients were diagnosed with a NET between 2013 and 2015 and captured by the National Cance...